share_log

Bruush Oral Care | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Yaletown Bros. Ventures Ltd.(2.8%),Matthew Friesen(2.8%), etc.

Bruush Oral Care | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Yaletown Bros. Ventures Ltd.(2.8%),Matthew Friesen(2.8%), etc.

Bruush Oral Care | SC 13D/A:超過5%持股股東披露文件(修正)-Yaletown Bros. Ventures Ltd.(2.8%),Matthew Friesen(2.8%)等
美股SEC公告 ·  02/23 22:23
Moomoo AI 已提取核心訊息
On February 23, 2024, Yaletown Bros. Ventures Ltd, along with individuals Matthew Friesen and Bradley Friesen, filed an Amendment No. 4 to Schedule 13D with the SEC, indicating changes in their ownership of Bruush Oral Care Inc. common shares. The group, which had previously reported ownership stakes ranging from 63% to 82%, now holds approximately 2.8% of the company's common shares, amounting to 2,810,602 shares. This change follows a series of open market transactions between February 16 and February 22, 2024, where the Reporting Persons sold a total of 2,919,500 shares. The transactions included the sale of shares at prices ranging from $0.0575 to $0.0825. The Friesens, through Yaletown Bros. Ventures Ltd, have ceased to be the beneficial owner of more than five percent of Bruush Oral Care's common shares. This filing represents the final amendment to the Schedule 13D for the Reporting Persons, signaling a significant reduction in their investment in the company.
On February 23, 2024, Yaletown Bros. Ventures Ltd, along with individuals Matthew Friesen and Bradley Friesen, filed an Amendment No. 4 to Schedule 13D with the SEC, indicating changes in their ownership of Bruush Oral Care Inc. common shares. The group, which had previously reported ownership stakes ranging from 63% to 82%, now holds approximately 2.8% of the company's common shares, amounting to 2,810,602 shares. This change follows a series of open market transactions between February 16 and February 22, 2024, where the Reporting Persons sold a total of 2,919,500 shares. The transactions included the sale of shares at prices ranging from $0.0575 to $0.0825. The Friesens, through Yaletown Bros. Ventures Ltd, have ceased to be the beneficial owner of more than five percent of Bruush Oral Care's common shares. This filing represents the final amendment to the Schedule 13D for the Reporting Persons, signaling a significant reduction in their investment in the company.
2024年2月23日,Yaletown Bros. Ventures Ltd與Matthew Friesen和Bradley Friesen等人一起向SEC提交了第4次修正的13D表,說明他們在Bruush Oral Care Inc.普通股所有權中的變化。該集團之前報告的股權持有份額在63%至82%之間,現在持有公司普通股約2.8%,即2810602股。此次變化發生在2024年2月16日至2月22日期間的一系列公開市場交易後,報告人共出售了2919500股股票。交易包括以0.0575美元至0.0825美元不等的價格出售股票。通過Yaletown Bros. Ventures Ltd,Friesen夫婦已停止成爲Bruush Oral Care普通股的五%以上的實際受益人。這份文件代表了報告人提交的第13D表的最終修訂,標誌着他們在該公司的投資顯著減少。
2024年2月23日,Yaletown Bros. Ventures Ltd與Matthew Friesen和Bradley Friesen等人一起向SEC提交了第4次修正的13D表,說明他們在Bruush Oral Care Inc.普通股所有權中的變化。該集團之前報告的股權持有份額在63%至82%之間,現在持有公司普通股約2.8%,即2810602股。此次變化發生在2024年2月16日至2月22日期間的一系列公開市場交易後,報告人共出售了2919500股股票。交易包括以0.0575美元至0.0825美元不等的價格出售股票。通過Yaletown Bros. Ventures Ltd,Friesen夫婦已停止成爲Bruush Oral Care普通股的五%以上的實際受益人。這份文件代表了報告人提交的第13D表的最終修訂,標誌着他們在該公司的投資顯著減少。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息